Search

everythinglearnresearchcommunity

for

Search:↓

Alstonia boonei phytochemicals show promise as alternative treatments for BPH with fewer side effects than current drugs.

Laser-assisted prostaglandin analogs improve hypopigmented scars safely, but more research is needed.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

New cancer treatments show promise in reducing tumor growth and improving skin regeneration in mice.

Plumbagin may help protect cells, reduce inflammation, and has potential for treating various diseases, but more research is needed.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

5-alpha-reductase inhibitors might help slow down low-risk prostate cancer, but their use should be cautious.

PRP therapy significantly regrows hair and satisfies patients without side effects.

Platelet Rich Plasma (PRP) treatment significantly improved Female Pattern Hair Loss in a study, but more trials are needed for confirmation.

BMPR1a-ECD reduces wrinkles much more effectively than retinoic acid.

The more lipophilic the progesterone derivative, the better it binds to androgen receptors and has antiandrogenic effects.

Finasteride inhibits enzyme activity in rhesus macaques, suggesting they're useful for evaluating similar drugs.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

The protein AtRXR3 limits root hair growth in Arabidopsis, affecting phosphorus uptake.

Ritlecitinib effectively treats alopecia areata in patients 12 and older with fewer side effects.

miR-203a-3p helps hair follicle stem cells become specialized by targeting Smad1.

Progesterone protects rat brain cells by enhancing GABA A receptor activity.

Hormonal contraceptives may reduce social behavior and sexual motivation by lowering allopregnanolone levels.

Platelet-rich plasma may not be very effective for bone healing and hair growth due to a substance it contains that blocks these processes.

Ritlecitinib significantly improves scalp hair regrowth in alopecia areata patients over time.

Nilotinib can cause keratosis pilaris, a skin condition.

The document highlights various patents for new compounds with potential treatments for multiple diseases, including cancer, hormonal disorders, and diabetes.

The new anti-acne treatment HA-P5 effectively reduces acne by targeting two key receptors and avoids an enzyme that can hinder treatment.

New compounds called benzoquinolinones may treat conditions linked to excess DHT.

The P133R mutation in AKR1D1 enzyme causes harmful bile acid buildup, explaining related health issues.

These medications for BPH have known risks and may have new side effects.

ATR12-351 ointment safely delivers LEKTI protein to the skin, reducing enzyme activity in Netherton syndrome.

A compound made by Pfizer can potentially stimulate hair growth and reduce oil production, making it a good candidate for topical use.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.